drugset / Trial / NCT01695876

A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), Food Effect of AMG 357 in Healthy Subjects

NCT01695876 ↗

Phase 1 Completed 58 enrolled Amgen
RandomizedCrossoverTriple-blindTreatment

Summary

Study to evaluate the safety, tolerability, PK, PD, and food effect of AMG 357 in healthy subjects

Timeline

Start
2012-10
Primary completion
2014-09
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject AMG 357 Small molecule — Oral

Indications